|
Advances in Skin & Wound Care
Online Submission and Review System
|
|
INSTRUCTIONS FOR AUTHORS
Advances in Skin & Wound Care, a peer-reviewed, interprofessional journal, publishes quantitative and qualitative original research, continuing education articles, scholarly reviews of the literature, reports on innovative treatments, case series, case studies, and practical articles for skin and wound care professionals. Published articles translate knowledge into practice for providers involved in skin and wound management: physicians, nurses, dermatologists, surgeons, podiatrists, physical and occupational therapists, dietitians, infection control practitioners, pharmacists, biomedical engineers, researchers, academics, and administrators.
The journal welcomes submissions of original articles in all areas of skin and wound management. Manuscripts are considered for publication only if the work has not been published and is not under consideration for publication by another periodical. All authors must disclose their affiliation(s) with organizations that have a direct or indirect financial interest in the editorial content and/or products that are discussed in the manuscript. Authors must state all relevant conflicts of interest in the manuscript, including financial, consultant, institutional, and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared.
Direct all correspondence and questions to:
Advances in Skin & Wound Care
Two Commerce Square
2001 Market Street
Philadelphia, PA 19103
Telephone: 215-521-8830
E-Mail: [email protected]
AUTHORSHIP, SUBMISSION, AND PUBLICATION
Manuscript Submission
All manuscripts must be submitted electronically to www.lwwesubmissions.com.
For further information and frequently asked questions about manuscript submission, listen to the following Words on Wounds podcast episodes:
Calling All Authors: Publishing with Advances in Skin & Wound Care
Addressing Authors’ Frequently Asked Questions: Tips for Successful Manuscript Submission
Review Process
All submitted papers are subject to a double-blind peer review. To facilitate blinding, the body of the manuscript and images, including credit lines, should not include identifiable information of any kind, including but not limited to author names/initials; facility names; or specific locations such as cities, provinces, or countries. If necessary, authors may identify this information as [[REDACTED FOR PEER REVIEW]].
The initial review process takes 2 to 3 months. Reviewer comments will be shared with the authors. If substantive revision is necessary, the manuscript will be returned to the authors for rework based on feedback from the Editor(s)-in-Chief and peer reviewers. Accepted manuscripts are subject to editorial revision for clarity, punctuation, grammar, syntax, and conformity to journal style. The corresponding author will receive a copy of the final manuscript for review prior to publication.
Artificial Intelligence (AI) Authoring Tools
Authors who use AI tools in the writing of a manuscript, production of images or graphical elements of the paper, or in the collection and analysis of data, must be transparent in disclosing in the Materials and Methods (or similar section) of the paper how the AI tool was used and which tool was used. Authors are fully responsible for the content of their manuscript, even those parts produced by an AI tool, and are thus liable for any breach of publication ethics.
Author Forms
Each submission must include:
- An author profile form from each author
- A confirmation of authorship/copyright transfer form completed by each author-
Please note, we cannot proceed with your manuscript until every co-author has completed the confirmation of authorship/copyright transfer form.
Author Profile Form
The author profile form can be found at the top of this page. Please attach all forms to the submission in Editorial Manager.
Confirmation of Authorship/Copyright Transfer Form
Each author must also submit the journal’s confirmation of authorship/copyright transfer agreement, which includes a section on the disclosure of potential conflicts of interest based on the recommendations of the ICMJE, “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” (www.icmje.org/update.html).
Copyright forms are collected electronically in Editorial Manager during the ‘Additional Information’ step of the submission process. The copyright form will be e-mailed to all co-authors upon submission using the information entered in the ‘Add/Edit/Remove Authors’ submission step. A copy of the form will be provided to the corresponding author.
All coauthors must complete this form in Editorial Manager upon manuscript submission: No action will be taken on any manuscript until all of the authorship forms are received. Please double-check all provided author emails for accuracy to facilitate this process.
The corresponding author may track co-author responses via the ‘Author Status’ action item in the ‘Submissions Being Processed’ or ‘Revisions Being Processed’ folders. It is also possible to edit a co-author’s e-mail address or resend the verification form; please contact the journal office for assistance.
Publication Timeline
Articles are published in the order in which they are accepted. We cannot honor requests to publish a manuscript in a particular issue or by a specific date. If you have questions about publication timing or average turnaround times, please email [email protected] prior to manuscript submission.
Social Media
In the digital age, social media has profound impacts on how scholars find new research and colleagues with similar interests around the world. To encourage conversation about your article, please visit this link for more information once it is published!
ARTICLE TYPES
Original Investigation
Original Investigations are scientific feature articles that create original data and translate new findings into practice for improved patient care. These articles should be no more than 5,000 words, including the abstract and references, and the reference list should be limited to 50 or fewer key recent references. See below for an in-depth description of the required article organization. Submissions exceeding this length will be returned to the author for revision.
Continuing Education (CE/NCPD/CME)
A continuing education article should review the recent literature and key concepts with an interpretation of the evidence for clinical practice. These articles should be written by practicing healthcare professionals and not employees of companies with conflicts of interest on the subject. The submission should be evidence-based and may follow a case format. The article may reflect scientific evidence, expert opinion, and/or patient preference, and should discuss the impact of the author conclusions/recommendations on healthcare systems when appropriate. These articles should be no more than 4,500 words, and the reference list should be limited to 25-40 key recent references. Submissions exceeding this length will be returned to the author for revision. The article must also include Practice Pearls: 4 or 5 bulleted sentences that summarize the main clinical takeaways of the article.
Literature Reviews
Reviews that provide a complete overview of the literature on any topic related to skin and wound care will be considered and will be subject to peer review. The journal accepts meta-analyses, narrative reviews, scoping reviews, and so on formatted in accordance with standardized reporting guidelines. The text should include a structured abstract of no more than 250 words under the following headings: Objective, Data Sources, Study Selection, Data Extraction, Data Synthesis, Conclusions. A Methods section detailing the chosen keywords, data sources, study selection process, and so on is required. These articles should be no more than 5,000 words, including the abstract and references. Submissions exceeding this length will be returned to the author for revision.
Case Report
A Case Report offers readers practical information about a single case that may be applicable to clinical care more broadly. The case may detail a rare condition/diagnosis or an unusual outcome; clinical images to accompany the case are encouraged. Case Reports must clearly state within the body of the manuscript that written informed consent was provided by the subject of the case to publish the case details and associated images, if any. Submissions without this statement will be immediately returned to the author. These articles should not exceed 2,500 words. Submissions exceeding this length will be returned to the author for revision.
Case Series
A Case Series offers readers practical information by describing a series of patients who have interesting outcomes of care. Case Series are any articles describing the specifics of more than one case, up to 12 patients. Clinical images to accompany the Series are encouraged. Case Series must clearly state within the body of the manuscript that written informed consent was provided by each subject to publish the case details and associated images, if any. Submissions without this statement will be immediately returned to the author. These articles should be no more than 4,000 words. Submissions exceeding this length will be returned to the author for revision.
Practice Reflections
This article type accommodates submissions that contribute to the larger discourse surrounding skin and wound care. Manuscripts may address recent innovations, current affairs, historical considerations, or broader systems-level concerns. Submissions should not exceed 2,500 words. Articles must incorporate expert opinion or experience and a clear awareness of the current literature on a given topic, as well as thorough referencing of up to 12 primary sources. These articles will be subject to peer review, although a double-blind review may not be possible in all cases.
Practice Points
These articles are intended for immediate use by practicing healthcare professionals and should comprise an extremely brief, practical overview of a single aspect of clinical care. The content should interpret the literature and present data, evidence, or guidelines in a format that can be easily implemented at the point of care. These articles must not exceed 1,500 words, or two printed pages of content. Submissions exceeding this length will be returned to the author for revision. Up to 5 key references may be included. A single figure or table is encouraged to illustrate the concept or enable translation to practice.
Letters to the Editor
Advances in Skin & Wound Care encourages this type of professional exchange. All submissions for this category must relate to recent publications. Letters that question, critique, or respond to a previously published paper will be sent to the author of that paper for a reply. Letters are reviewed by the Editor(s)-in-Chief for suitability before publication. They must be signed and are subject to editing for style and length. Letters should be between 500 and 1,500 words in length and should be submitted to [email protected], NOT Editorial Manager, with the subject line "Letter to the Editor."
STYLE GUIDE
Original Investigation Article Organization
- Title Page: Should include the following:
- The article title
- The full name of each author, all credentials including highest academic degree, and current job/position title and affiliation, including city and state (eg, Jamie Smith, PhD, RN, Associate Professor, School of Medicine, Arizona State University, Tempe, Arizona, USA) listed in publication order.
- Please note that Advances in Skin & Wound Care does not designate corresponding or first authors.
- Any conflicts of interest and funding received for this work from any of the following organizations: National Institutes of Health (NIH), Wellcome Trust, Howard Hughes Medical Institute (HHMI), and other(s). Funding disclosures should be specific and clearly state what support was provided, eg, study materials, travel reimbursement, editorial support, etc.
- Abstract: A structured abstract of no more than 250 words included within the body of the manuscript should contain the following headings: Objective, Methods, Results, Conclusions, and 6 Keywords in alphabetical order separated by commas.
- Text: Do not number manuscript sections. The body of the manuscript may include the following:
- Introduction (including a brief literature review, statement of the problem/clinical relevance, study objective)
- Methods (including study design, setting, participants, inclusion/exclusion criteria, materials, procedure, etc)
- Regardless of type, every manuscript involving living beings must include an ethics section that addresses institutional review/approval, blinding and data anonymity, and/or participant/guardian informed consent, even if the study was exempt or retrospective in nature. Submissions that do not address this will be immediately returned to the author.
- Results
- Discussion (including limitations)
- Conclusions (including implications for practice and recommendations for future study)
References
Authors must use a modified AMA (American Medical Association) style for references. Do not use endnotes in the text. Number each reference consecutively from the first time it is cited in the text using superscript numbers, placed after the punctuation. List all authors when there are 6 or fewer; for 7 or more, list the first 3 authors followed by "et al." Authors are responsible for the accuracy of all relevant citations.
- Journal article: Author(s) (last name and initials, no periods), title of article (lowercase, no quotation marks), abbreviation of the journal as given in the Cumulative Index Medicus, year of publication, volume number, and inclusive pages.
- Example: Sibbald RG, Elliott JA, Persaud-Jaimangal R, et al. Wound bed preparation 2021. Adv Skin Wound Care 2021;34:183-95.
- Publication by an organization: Follow example format; include a hyperlink and last accessed date.
- Example: National Pressure Injury Advisory Panel. Pressure Injury Stages. 2016. https://npiap.com/page/PressureInjuryStages. Last accessed October 14, 2020.
- Book: Author(s) (last name and initials, no periods), title (uppercase and lowercase, no quotation marks), edition or volume, city and state/province of publication, publisher, and year.
- Example: Lemeshow S, Hosmer DW, Klar J, Lwanga SK. Adequacy of Sample Size in Health Studies. Chichester, England: John Wiley & Sons Ltd, 2018.
- Chapter in a book: Follow the directions for book title but add chapter title and editors.
- Example: Brandeis G, Powell J, Bergstrom M. Resident assessment protocol: pressure ulcers. In: Morris JN, Hawes C, Murphey K, et al, eds. Resident Assessment Instrument Training and Resource Guide. Natick, MA: Eliot Press; 2020.
Art Items
- Art items should be submitted as separate file(s).
- Articles should have no more than 6-8 art items, proportional to the length of the manuscript. Figures with multiple parts count as multiple items. Excess or overly long tables and figures will be published online as supplemental digital content at the discretion of the editors.
- If using previously published material, authors are responsible for obtaining written permission from the copyright holder before submission.
- Tables: Include a title for each table. Number the tables in the order in which they are referred to in the text. Any abbreviations, footnotes, and appropriate credit lines should be listed at the bottom of the table.
- Figures: Must be submitted as individual high-resolution electronic files in .tif, .png, or .jpg format. If a figure has multiple parts (Figure 1a, Figure 1b), each must be submitted as a separate file. Images inserted into a Word document are not acceptable. Include a title for each image. Number the figures in the order in which they are referred to in the text. Written permission from the subject must accompany photographs. Model release forms can be supplied if needed.
Journal Style
Authors should incorporate the following style considerations into their manuscripts before submission:
- Use American English spellings and grammar conventions.
- Refer to products, devices, and medications by their generic names throughout the manuscript. Include a product name and manufacturer only at the first mention. Trademark and registration symbols should not be used.
- Third person (study authors, researchers, investigators, etc) active voice is preferred. Avoid passive voice.
- Spell out all abbreviations at first mention. Abbreviations should only be used for terms that appear three or more times in the text.
- Use patient-first language: eg, persons with diabetes, NOT diabetics.
- Note updated terminology: pressure injuries (PIs) and hospital-acquired pressure injuries (HAPIs). Other terminology is acceptable only when referring to previous research or historical contexts.
- Note the following statistical/special character conventions: P < .05; n = 580; χ2 test; TNF-α
Clinical Trials
Manuscripts about a clinical trial must meet the ICMJE clinical trial registration and data sharing policy.
- As of July 1, 2018, manuscripts submitted that report the results of clinical trials must contain a data-sharing statement.
- Clinical trials that began enrolling participants on or after January 1, 2019 must include a data-sharing plan in the trial’s registration.
The ICMJE defines a clinical trial as any research project that prospectively assigns people or a group of people to an intervention, with or without concurrent comparison or control groups, to study the relationship between a health-related intervention and a health outcome. For more information, visit the ICMJE Clinical Trials site.
Compliance with NIH and Other Research Funding Agency Accessibility Requirements
A number of research funding agencies now require or request authors to submit the post-print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, LWW will identify to the National Library of Medicine (NLM) articles that require deposit and will transmit the post-print of an article based on research funded in whole or in part by the National Institutes of Health, Wellcome Trust, Howard Hughes Medical Institute, or other funding agencies to PubMed Central. The revised Copyright Transfer Agreement provides the mechanism for this process.
OPEN ACCESS
Authors of accepted peer-reviewed articles have the choice to pay a fee to allow perpetual unrestricted online access to their published article to readers globally, immediately upon publication. Authors may take advantage of the open access option at the point of acceptance to ensure that this choice has no influence on the peer review and acceptance process. These articles are subject to the journal's standard peer-review process and will be accepted or rejected based on their own merit.
The article processing charge (APC) is charged on acceptance of the article and should be paid within 30 days by the author, funding agency, or institution. Payment must be processed for the article to be published open access. For a list of journals and pricing, please visit our Wolters Kluwer Open Health Journals page.
Authors retain copyright
Authors retain their copyright for all articles they opt to publish open access. Authors grant Wolters Kluwer an exclusive license to publish the article and the article is made available under the terms of a Creative Commons user license. Please visit our Open Access Publication Process page for more information.
Creative Commons license
Open access articles are freely available to read, download, and share from the time of publication under the terms of the Creative Commons License Attribution-NonCommerical No Derivative (CC BY-NC-ND) license. This license does not permit reuse for any commercial purposes nor does it cover the reuse or modification of individual elements of the work (such as figures, tables, etc.) in the creation of derivative works without specific permission.
Compliance with funder mandated open access policies
An author whose work is funded by an organization that mandates the use of the Creative Commons Attribution (CC BY) license is able to meet that requirement through the available open access license for approved funders. Information about the approved funders can be found here: http://www.wkopenhealth.com/inst-fund.php
FAQ for open access
http://www.wkopenhealth.com/openaccessfaq.php
